checkAd
    Startseite > Aktien > Zevra Therapeutics > Nachrichten
    Zevra Therapeutics Aktie
    4,8200
     
    USD
    -4,17 %
    -0,2100 USD
    Letzter Kurs 11.05.24 Nasdaq
    4,8200
     
    USD
    500 STK
    Geldkurs 10.05.24
    4,8400
     
    USD
    700 STK
    Briefkurs 10.05.24
    ISIN: US4884452065 · WKN: A2QLX7 · SYM: ZVRA · USA

    Neueste Nachrichten

    Zevra Therapeutics to Participate at Upcoming Investor Events
    09.05.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
    08.05.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics to Report First Quarter 2024 Results on May 8, 2024
    01.05.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics’ President and Chief Executive Officer Issues Letter to Stockholders Highlighting Recent Key Accomplishments and Outlook for 2024
    29.04.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
    15.04.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility
    10.04.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
    28.03.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia
    26.03.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
    25.03.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024
    18.03.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
    04.03.24 · globenewswire · Zevra Therapeutics
    Zevra Therapeutics to Participate at Upcoming Investor Conferences
    28.02.24 · globenewswire · Zevra Therapeutics